Benjamin Bikman is a PhD metabolic scientist known for his research on insulin resistance and its role in chronic disease. He joined Sean Kelly on the Digital Social Hour to break down what visceral fat actually is, why it behaves differently across ethnic groups, and what his research suggests about managing it.
The conversation ranges from the biology of fat cells to the broader debate around treatments like Ozempic, with Bikman walking through his own studies and how they hold up against the wider body of metabolic research.
About Benjamin Bikman
Benjamin Bikman holds a PhD and has built his career studying insulin resistance, metabolic disease, and the biology of body fat. He is the author of Why We Get Sick, which lays out his perspective on how insulin resistance connects to conditions ranging from obesity to type 2 diabetes.
His research examines how visceral fat — the fat stored around internal organs — differs from fat stored elsewhere in the body, and why certain populations may face a lower threshold before that fat becomes harmful. Bikman frequently shares his findings and commentary with a broader public audience, translating laboratory research into practical, if carefully caveated, discussion.
What Benjamin Bikman and Sean Kelly Talked About
- How Benjamin Bikman defines visceral fat and why it behaves differently from fat stored elsewhere
- Why he believes some ethnic groups face a lower fat threshold before health risks rise
- His research on the link between insulin resistance and the global rise in obesity
- How fat cell size and number factor into his broader theory of metabolic disease
- His take on the ongoing debate around Ozempic and other weight-loss medications
- Why he examines the connection between insulin resistance, sleep, and long-term brain health
- How his lab's findings compare against rodent studies and the wider research literature
- His perspective on creatine's potential role in supporting brain health
Why This Conversation Matters
Benjamin Bikman is one of the more prominent researchers translating metabolic science for a general audience, and this conversation gives him room to explain, in his own words, why he considers visceral fat and insulin resistance central to understanding chronic disease. It's a valuable primer for anyone trying to make sense of the broader conversation around metabolic health — presented as his scientific perspective, not a substitute for individual medical care.
▶ Watch the full episode on YouTube
Related Digital Social Hour Episodes
About Sean Kelly & the Digital Social Hour
Sean Kelly is an entrepreneur and the host of the Digital Social Hour, one of the fastest-growing interview podcasts in the world, where he sits down with entrepreneurs, athletes, creators, and cultural voices for candid, long-form conversations. The show draws over 100 million views a month across platforms. Explore more guest features on SeanKelly.io.
About The Author
